Kathrin Jansen — SPARQNOW

At-a-Glance

Former Head of Vaccine R&D at Pfizer, a role she held since 2009.
Led the development of Gardasil®, the world’s first cervical cancer vaccine, at Merck.
Led the development of the Pfizer–BioNTech COVID-19 vaccine, approved for Emergency Use Authorization in the US on December 11, 2020.
Oversaw development of Prevnar13® for pneumococcal diseases and Trumenba® for Neisseria meningitidis serogroup B.
Member of the Coalition for Epidemic Preparedness Innovations (CEPI) scientific advisory committee.
Holds a doctoral degree in Microbiology, biochemistry, and genetics from the University of Marburg.

Biography

Kathrin Jansen is the former Head of Vaccine Research and Development at Pfizer, a role she held since 2009. As a member of Pfizer’s Worldwide Research, Development, and Medical leadership team, she led a global vaccines R&D organization, overseeing activities from discovery to registration and post-marketing.